<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338537</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1863</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12091863</ELocationID><Abstract><AbstractText>As of 2024, SARS-CoV-2 continues to propagate and drift as an endemic virus, impacting healthcare for years. The largest sequencing initiative for any species was initiated to combat the virus, tracking changes over time at a full virus base-pair resolution. The SARS-CoV-2 sequencing represents a unique opportunity to understand selective pressures and viral evolution but requires cross-disciplinary approaches from epidemiology to functional protein biology. Within this work, we integrate a two-year genotyping window with structural biology to explore the selective pressures of SARS-CoV-2 on protein insights. Although genotype and the Spike (Surface Glycoprotein) protein continue to drift, most SARS-CoV-2 proteins have had few amino acid alterations. Within Spike, the high drift rate of amino acids involved in antibody evasion also corresponds to changes within the ACE2 binding pocket that have undergone multiple changes that maintain functional binding. The genotyping suggests selective pressure for receptor specificity that could also confer changes in viral risk. Mapping of amino acid changes to the structures of the SARS-CoV-2 co-transcriptional complex (nsp7-nsp14), nsp3 (papain-like protease), and nsp5 (cysteine protease) proteins suggest they remain critical factors for drug development that will be sustainable, unlike those strategies targeting Spike.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prokop</LastName><ForeName>Jeremy W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberta</LastName><ForeName>Sheryl</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Advanced Technology Lab, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witteveen-Lane</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pell</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Advanced Technology Lab, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farag</LastName><ForeName>Hosam A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhargava</LastName><ForeName>Disha</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaughan</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-3046-4207</Identifier><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frisch</LastName><ForeName>Austin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauss</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatti</LastName><ForeName>Humza</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0008-0245-8994</Identifier><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>Sanjana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subrahmanya</LastName><ForeName>Charitha</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearson</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodyke</LastName><ForeName>Austin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westgate</LastName><ForeName>Mason</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Taylor W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Jackson T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zieba</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Genome Sciences Program, BioMolecular Science, Michigan State University, East Lansing, MI 48824, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sims</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, Corewell Health, Royal Oak, MI 48073, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Oakland University William Beaumont School of Medicine, Auburn Hills, MI 48309, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Underwood</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8232-4129</Identifier><AffiliationInfo><Affiliation>Division of Mathematics and Science, Walsh University, North Canton, OH 44720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassouna</LastName><ForeName>Habiba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Adult Infectious Disease, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajasekaran</LastName><ForeName>Surender</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamae Kakazu</LastName><ForeName>Maximiliano A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-4943-1656</Identifier><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chesla</LastName><ForeName>Dave</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Office of Research, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivero</LastName><ForeName>Rosemary</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5417-4650</Identifier><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Infectious Disease, Helen DeVos Children's Hospital, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caulfield</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Microbiology Lab, Corewell Health, Grand Rapids, MI 49503, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N/A</GrantID><Agency>MI-SAPPHIRE</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Spike</Keyword><Keyword MajorTopicYN="N">cysteine protease</Keyword><Keyword MajorTopicYN="N">drift</Keyword><Keyword MajorTopicYN="N">nonstructural protein</Keyword><Keyword MajorTopicYN="N">papain-like protease</Keyword><Keyword MajorTopicYN="N">viral genome</Keyword></KeywordList><CoiStatement>None of the authors have declared any significant conflicts of interest relative to this work. Corewell Health is a not for profit hospital system in the USA.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338537</ArticleId><ArticleId IdType="pmc">PMC11433680</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12091863</ArticleId><ArticleId IdType="pii">microorganisms12091863</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hatcher E.L., Zhdanov S.A., Bao Y., Blinkova O., Nawrocki E.P., Ostapchuck Y., Schäffer A.A., Brister J.R. Virus Variation Resource—Improved Response to Emergent Viral Outbreaks. Nucleic Acids Res. 2017;45:D482–D490. doi: 10.1093/nar/gkw1065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1065</ArticleId><ArticleId IdType="pmc">PMC5210549</ArticleId><ArticleId IdType="pubmed">27899678</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu Y., McCauley J. GISAID: Global Initiative on Sharing All Influenza Data—From Vision to Reality. Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull. 2017;22:30494. doi: 10.2807/1560-7917.ES.2017.22.13.30494.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.13.30494</ArticleId><ArticleId IdType="pmc">PMC5388101</ArticleId><ArticleId IdType="pubmed">28382917</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M.A., VanInsberghe D., Koelle K. Insights from SARS-CoV-2 Sequences. Science. 2021;371:466–467. doi: 10.1126/science.abf3995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf3995</ArticleId><ArticleId IdType="pubmed">33510015</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey W.T., Carabelli A.M., Jackson B., Gupta R.K., Thomson E.C., Harrison E.M., Ludden C., Reeve R., Rambaut A., COVID-19 Genomics UK (COG-UK) Consortium et al. SARS-CoV-2 Variants, Spike Mutations and Immune Escape. Nat. Rev. Microbiol. 2021;19:409–424. doi: 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Lee J.-Y., Yang J.-S., Kim J.W., Kim V.N., Chang H. The Architecture of SARS-CoV-2 Transcriptome. Cell. 2020;181:914–921.e10. doi: 10.1016/j.cell.2020.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.011</ArticleId><ArticleId IdType="pmc">PMC7179501</ArticleId><ArticleId IdType="pubmed">32330414</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K., Tzou P.L., Nouhin J., Gupta R.K., de Oliveira T., Kosakovsky Pond S.L., Fera D., Shafer R.W. The Biological and Clinical Significance of Emerging SARS-CoV-2 Variants. Nat. Rev. Genet. 2021;22:757–773. doi: 10.1038/s41576-021-00408-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00408-x</ArticleId><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ba A.A., Coppée R., Dieng A., Manneh J., Fall M., Gueye K., Sene P.Y., Ndiour S., Samaté D., Manga P., et al. Genomic Epidemiology of SARS-CoV-2 in Senegal in 2020–2021. J. Infect. Dev. Ctries. 2024;18:851–861. doi: 10.3855/jidc.17796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.17796</ArticleId><ArticleId IdType="pubmed">38990988</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado L.C., Dezordi F.Z., de Lima G.B., de Lima R.E., Silva L.C.A., Pereira L.d.M., da Silva A.F., Silva Neto A.M.d., Oliveira A.L.S.d., Armstrong A.d.C., et al. Spatiotemporal Transmission of SARS-CoV-2 Lineages during 2020-2021 in Pernambuco-Brazil. Microbiol. Spectr. 2024;12:e0421823. doi: 10.1128/spectrum.04218-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.04218-23</ArticleId><ArticleId IdType="pmc">PMC11237429</ArticleId><ArticleId IdType="pubmed">38651879</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairnar K., Tomar S.S. COVID-19 Genome Surveillance: A Geographical Landscape and Mutational Mapping of SARS-CoV-2 Variants in Central India over Two Years. Virus Res. 2024;344:199365. doi: 10.1016/j.virusres.2024.199365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2024.199365</ArticleId><ArticleId IdType="pmc">PMC10998191</ArticleId><ArticleId IdType="pubmed">38527669</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagare A., Faye M., Issa M., Hamidou O., Bienvenu B., Mohamed A., Aoula B., Moumouni K., Hassane F., Otto Y.A., et al. First Identification of the SARS-COV-2/XBB.1.5 Sublineage among Indigenous COVID-19 Cases through the Influenza Sentinel Surveillance System in Niger. Heliyon. 2023;9:e20916. doi: 10.1016/j.heliyon.2023.e20916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e20916</ArticleId><ArticleId IdType="pmc">PMC10637901</ArticleId><ArticleId IdType="pubmed">37954288</ArticleId></ArticleIdList></Reference><Reference><Citation>Walensky R.P., Walke H.T., Fauci A.S. SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities. JAMA. 2021;325:1037–1038. doi: 10.1001/jama.2021.2294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2294</ArticleId><ArticleId IdType="pmc">PMC9009864</ArticleId><ArticleId IdType="pubmed">33595644</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiara M., D’Erchia A.M., Gissi C., Manzari C., Parisi A., Resta N., Zambelli F., Picardi E., Pavesi G., Horner D.S., et al. Next Generation Sequencing of SARS-CoV-2 Genomes: Challenges, Applications and Opportunities. Brief. Bioinform. 2021;22:616–630. doi: 10.1093/bib/bbaa297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa297</ArticleId><ArticleId IdType="pmc">PMC7799330</ArticleId><ArticleId IdType="pubmed">33279989</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R., Charron J., Stenger C.L., Painter J., Steward H., Cook T.W., Faber W., Frisch A., Lind E., Bauss J., et al. SARS-CoV-2 (COVID-19) Structural and Evolutionary Dynamicome: Insights into Functional Evolution and Human Genomics. J. Biol. Chem. 2020;295:11742–11753. doi: 10.1074/jbc.RA120.014873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.014873</ArticleId><ArticleId IdType="pmc">PMC7450099</ArticleId><ArticleId IdType="pubmed">32587094</ArticleId></ArticleIdList></Reference><Reference><Citation>Brister J.R., Ako-Adjei D., Bao Y., Blinkova O. NCBI Viral Genomes Resource. Nucleic Acids Res. 2015;43:D571–D577. doi: 10.1093/nar/gku1207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1207</ArticleId><ArticleId IdType="pmc">PMC4383986</ArticleId><ArticleId IdType="pubmed">25428358</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassmann T., Sonnhammer E.L.L. Kalign—An Accurate and Fast Multiple Sequence Alignment Algorithm. BMC Bioinform. 2005;6:298. doi: 10.1186/1471-2105-6-298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-6-298</ArticleId><ArticleId IdType="pmc">PMC1325270</ArticleId><ArticleId IdType="pubmed">16343337</ArticleId></ArticleIdList></Reference><Reference><Citation>Okonechnikov K., Golosova O., Fursov M. UGENE team Unipro UGENE: A Unified Bioinformatics Toolkit. Bioinformatics. 2012;28:1166–1167. doi: 10.1093/bioinformatics/bts091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts091</ArticleId><ArticleId IdType="pubmed">22368248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Tamura K., Nei M. MEGA: Molecular Evolutionary Genetics Analysis Software for Microcomputers. Comput. Appl. Biosci. CABIOS. 1994;10:189–191. doi: 10.1093/bioinformatics/10.2.189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/10.2.189</ArticleId><ArticleId IdType="pubmed">8019868</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman H., Henrick K., Nakamura H., Markley J.L. The Worldwide Protein Data Bank (wwPDB): Ensuring a Single, Uniform Archive of PDB Data. Nucleic Acids Res. 2007;35:D301–D303. doi: 10.1093/nar/gkl971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl971</ArticleId><ArticleId IdType="pmc">PMC1669775</ArticleId><ArticleId IdType="pubmed">17142228</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L., Yang Y., Li M., Zhang Y., Zheng L., Ge J., Huang Y.C., Liu Z., Wang T., Gao S., et al. Coupling of N7-Methyltransferase and 3′-5′ Exoribonuclease with SARS-CoV-2 Polymerase Reveals Mechanisms for Capping and Proofreading. Cell. 2021;184:3474–3485.e11. doi: 10.1016/j.cell.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8142856</ArticleId><ArticleId IdType="pubmed">34143953</ArticleId></ArticleIdList></Reference><Reference><Citation>Klemm T., Ebert G., Calleja D.J., Allison C.C., Richardson L.W., Bernardini J.P., Lu B.G., Kuchel N.W., Grohmann C., Shibata Y., et al. Mechanism and Inhibition of the Papain-like Protease, PLpro, of SARS-CoV-2. EMBO J. 2020;39:e106275. doi: 10.15252/embj.2020106275.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106275</ArticleId><ArticleId IdType="pmc">PMC7461020</ArticleId><ArticleId IdType="pubmed">32845033</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewitz L., Dumjahn L., Zhao Y., Owen C.D., Laidlaw S.M., Malla T.R., Nguyen D., Lukacik P., Salah E., Crawshaw A.D., et al. Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine. J. Med. Chem. 2023;66:2663–2680. doi: 10.1021/acs.jmedchem.2c01627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.2c01627</ArticleId><ArticleId IdType="pmc">PMC9924091</ArticleId><ArticleId IdType="pubmed">36757959</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger E., Koraimann G., Vriend G. Increasing the Precision of Comparative Models with YASARA NOVA--a Self-Parameterizing Force Field. Proteins. 2002;47:393–402. doi: 10.1002/prot.10104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.10104</ArticleId><ArticleId IdType="pubmed">11948792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouranov A., Xie L., de la Cruz J., Chen L., Westbrook J., Bourne P.E., Berman H.M. The RCSB PDB Information Portal for Structural Genomics. Nucleic Acids Res. 2006;34:D302–D305. doi: 10.1093/nar/gkj120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkj120</ArticleId><ArticleId IdType="pmc">PMC1347482</ArticleId><ArticleId IdType="pubmed">16381872</ArticleId></ArticleIdList></Reference><Reference><Citation>Parums D.V. Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and Its Rapid Global Spread. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2023;29:e939580. doi: 10.12659/MSM.939580.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.939580</ArticleId><ArticleId IdType="pmc">PMC9901170</ArticleId><ArticleId IdType="pubmed">36722047</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaway E. Coronavirus Variant XBB.1.5 Rises in the United States—Is It a Global Threat? Nature. 2023;613:222–223. doi: 10.1038/d41586-023-00014-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-00014-3</ArticleId><ArticleId IdType="pubmed">36624320</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercatelli D., Giorgi F.M. Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Front. Microbiol. 2020;11:1800. doi: 10.3389/fmicb.2020.01800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01800</ArticleId><ArticleId IdType="pmc">PMC7387429</ArticleId><ArticleId IdType="pubmed">32793182</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza N., Rahat B., Naqvi B., Rizvi S.K.A. Impact of Covid-19 on Corporate Solvency and Possible Policy Responses in the EU. Q. Rev. Econ. Finance J. Midwest Econ. Assoc. 2023;87:181–190. doi: 10.1016/j.qref.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.qref.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7507986</ArticleId><ArticleId IdType="pubmed">32982131</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez E., Bielska I.A., Hopkins S., Belal A.A., Goldstein D.M., Slick J., Pavalagantharajah S., Wynfield A., Dakey S., Gedeon M.-C., et al. Limitations of COVID-19 Testing and Case Data for Evidence-Informed Health Policy and Practice. Health Res. Policy Syst. 2023;21:11. doi: 10.1186/s12961-023-00963-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12961-023-00963-1</ArticleId><ArticleId IdType="pmc">PMC9876649</ArticleId><ArticleId IdType="pubmed">36698202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartog N., Faber W., Frisch A., Bauss J., Bupp C.P., Rajasekaran S., Prokop J.W. SARS-CoV-2 Infection: Molecular Mechanisms of Severe Outcomes to Suggest Therapeutics. Expert Rev. Proteomics. 2021;18:105–118. doi: 10.1080/14789450.2021.1908894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14789450.2021.1908894</ArticleId><ArticleId IdType="pmc">PMC8022340</ArticleId><ArticleId IdType="pubmed">33779460</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirpilla O., Bauss J., Gupta R., Underwood A., Qutob D., Freeland T., Bupp C., Carcillo J., Hartog N., Rajasekaran S., et al. SARS-CoV-2-Encoded Proteome and Human Genetics: From Interaction-Based to Ribosomal Biology Impact on Disease and Risk Processes. J. Proteome Res. 2020;19:4275–4290. doi: 10.1021/acs.jproteome.0c00421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00421</ArticleId><ArticleId IdType="pmc">PMC7418564</ArticleId><ArticleId IdType="pubmed">32686937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A., Li F. Structural Basis of Receptor Recognition by SARS-CoV-2. Nature. 2020;581:221–224. doi: 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin W., Xu Y., Xu P., Cao X., Wu C., Gu C., He X., Wang X., Huang S., Yuan Q., et al. Structures of the Omicron Spike Trimer with ACE2 and an Anti-Omicron Antibody. Science. 2022;375:1048–1053. doi: 10.1126/science.abn8863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn8863</ArticleId><ArticleId IdType="pmc">PMC8939775</ArticleId><ArticleId IdType="pubmed">35133176</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastorio C., Zech F., Noettger S., Jung C., Jacob T., Sanderson T., Sparrer K.M.J., Kirchhoff F. Determinants of Spike Infectivity, Processing, and Neutralization in SARS-CoV-2 Omicron Subvariants BA.1 and BA.2. Cell Host Microbe. 2022;30:1255–1268.e5. doi: 10.1016/j.chom.2022.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.07.006</ArticleId><ArticleId IdType="pmc">PMC9289044</ArticleId><ArticleId IdType="pubmed">35931073</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhivker G. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Int. J. Mol. Sci. 2020;21:8268. doi: 10.3390/ijms21218268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218268</ArticleId><ArticleId IdType="pmc">PMC7672574</ArticleId><ArticleId IdType="pubmed">33158276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R., Canena D., Sikora M., Klausberger M., Seferovic H., Mehdipour A.R., Hain L., Laurent E., Monteil V., Wirnsberger G., et al. Force-Tuned Avidity of Spike Variant-ACE2 Interactions Viewed on the Single-Molecule Level. Nat. Commun. 2022;13:7926. doi: 10.1038/s41467-022-35641-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35641-3</ArticleId><ArticleId IdType="pmc">PMC9789309</ArticleId><ArticleId IdType="pubmed">36566234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakavandi S., Zare I., VaezJalali M., Dadashi M., Azarian M., Akbari A., Ramezani Farani M., Zalpoor H., Hajikhani B. Structural and Non-Structural Proteins in SARS-CoV-2: Potential Aspects to COVID-19 Treatment or Prevention of Progression of Related Diseases. Cell Commun. Signal. CCS. 2023;21:110. doi: 10.1186/s12964-023-01104-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-023-01104-5</ArticleId><ArticleId IdType="pmc">PMC10183699</ArticleId><ArticleId IdType="pubmed">37189112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynes R.O. Cell Surface Proteins and Malignant Transformation. Biochim. Biophys. Acta. 1976;458:73–107. doi: 10.1016/0304-419X(76)90015-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-419X(76)90015-9</ArticleId><ArticleId IdType="pubmed">779852</ArticleId></ArticleIdList></Reference><Reference><Citation>Choppin P.W., Scheid A. The Role of Viral Glycoproteins in Adsorption, Penetration, and Pathogenicity of Viruses. Rev. Infect. Dis. 1980;2:40–61. doi: 10.1093/clinids/2.1.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/2.1.40</ArticleId><ArticleId IdType="pubmed">6994202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynes R.O. Alteration of Cell-Surface Proteins by Viral Transformation and by Proteolysis. Proc. Natl. Acad. Sci. USA. 1973;70:3170–3174. doi: 10.1073/pnas.70.11.3170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.70.11.3170</ArticleId><ArticleId IdType="pmc">PMC427194</ArticleId><ArticleId IdType="pubmed">4361679</ArticleId></ArticleIdList></Reference><Reference><Citation>Vossen M.T.M., Westerhout E.M., Söderberg-Nauclér C., Wiertz E.J.H.J. Viral Immune Evasion: A Masterpiece of Evolution. Immunogenetics. 2002;54:527–542. doi: 10.1007/s00251-002-0493-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-002-0493-1</ArticleId><ArticleId IdType="pubmed">12439615</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch M. Mutation Pressure, Drift, and the Pace of Molecular Coevolution. Proc. Natl. Acad. Sci. USA. 2023;120:e2306741120. doi: 10.1073/pnas.2306741120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2306741120</ArticleId><ArticleId IdType="pmc">PMC10319038</ArticleId><ArticleId IdType="pubmed">37364099</ArticleId></ArticleIdList></Reference><Reference><Citation>Magadum S., Banerjee U., Murugan P., Gangapur D., Ravikesavan R. Gene Duplication as a Major Force in Evolution. J. Genet. 2013;92:155–161. doi: 10.1007/s12041-013-0212-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12041-013-0212-8</ArticleId><ArticleId IdType="pubmed">23640422</ArticleId></ArticleIdList></Reference><Reference><Citation>Koonin E.V., Dolja V.V., Krupovic M. Origins and Evolution of Viruses of Eukaryotes: The Ultimate Modularity. Virology. 2015;479–480:2–25. doi: 10.1016/j.virol.2015.02.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.039</ArticleId><ArticleId IdType="pmc">PMC5898234</ArticleId><ArticleId IdType="pubmed">25771806</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner B.G., Summers M.F. Structural Biology of HIV. J. Mol. Biol. 1999;285:1–32. doi: 10.1006/jmbi.1998.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1998.2354</ArticleId><ArticleId IdType="pubmed">9878383</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaikwad S.Y., Phatak P., Mukherjee A. Cutting Edge Strategies for Screening of Novel Anti-HIV Drug Candidates against HIV Infection: A Concise Overview of Cell Based Assays. Heliyon. 2023;9:e16027. doi: 10.1016/j.heliyon.2023.e16027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e16027</ArticleId><ArticleId IdType="pmc">PMC10195898</ArticleId><ArticleId IdType="pubmed">37215829</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu I.-L., Mahindroo N., Liang P.-H., Peng Y.-H., Kuo C.-J., Tsai K.-C., Hsieh H.-P., Chao Y.-S., Wu S.-Y. Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease. J. Med. Chem. 2006;49:5154–5161. doi: 10.1021/jm060207o.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm060207o</ArticleId><ArticleId IdType="pubmed">16913704</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble C.G., Shi P.-Y. Structural Biology of Dengue Virus Enzymes: Towards Rational Design of Therapeutics. Antiviral Res. 2012;96:115–126. doi: 10.1016/j.antiviral.2012.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.09.007</ArticleId><ArticleId IdType="pubmed">22995600</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox B.D., Stanton R.A., Schinazi R.F. Predicting Zika Virus Structural Biology: Challenges and Opportunities for Intervention. Antivir. Chem. Chemother. 2015;24:118–126. doi: 10.1177/2040206616653873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2040206616653873</ArticleId><ArticleId IdType="pmc">PMC5890524</ArticleId><ArticleId IdType="pubmed">27296393</ArticleId></ArticleIdList></Reference><Reference><Citation>Penin F., Dubuisson J., Rey F.A., Moradpour D., Pawlotsky J.-M. Structural Biology of Hepatitis C Virus. Hepatol. Baltim. Md. 2004;39:5–19. doi: 10.1002/hep.20032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20032</ArticleId><ArticleId IdType="pubmed">14752815</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Hu L., Dong G., Zhang Y., Ferreira da Silva-Júnior E., Liu X., Menéndez-Arias L., Zhan P. Emerging Drug Design Strategies in Anti-Influenza Drug Discovery. Acta Pharm. Sin. B. 2023;13:4715–4732. doi: 10.1016/j.apsb.2023.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2023.08.010</ArticleId><ArticleId IdType="pmc">PMC10692392</ArticleId><ArticleId IdType="pubmed">38045039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemian S.M.R., Sheida A., Taghizadieh M., Memar M.Y., Hamblin M.R., Bannazadeh Baghi H., Sadri Nahand J., Asemi Z., Mirzaei H. Paxlovid (Nirmatrelvir/Ritonavir): A New Approach to Covid-19 Therapy? Biomed. Pharmacother. Biomed. Pharmacother. 2023;162:114367. doi: 10.1016/j.biopha.2023.114367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114367</ArticleId><ArticleId IdType="pmc">PMC9899776</ArticleId><ArticleId IdType="pubmed">37018987</ArticleId></ArticleIdList></Reference><Reference><Citation>Focosi D., Maggi F., McConnell S., Casadevall A. Very Low Levels of Remdesivir Resistance in SARS-COV-2 Genomes after 18 Months of Massive Usage during the COVID19 Pandemic: A GISAID Exploratory Analysis. Antiviral Res. 2022;198:105247. doi: 10.1016/j.antiviral.2022.105247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105247</ArticleId><ArticleId IdType="pmc">PMC8755559</ArticleId><ArticleId IdType="pubmed">35033572</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahankhani K., Ahangari F., Adcock I.M., Mortaz E. Possible Cancer-Causing Capacity of COVID-19: Is SARS-CoV-2 an Oncogenic Agent? Biochimie. 2023;213:130–138. doi: 10.1016/j.biochi.2023.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2023.05.014</ArticleId><ArticleId IdType="pmc">PMC10202899</ArticleId><ArticleId IdType="pubmed">37230238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugl A., Andersen C.L. Epstein-Barr Virus and Its Association with Disease—A Review of Relevance to General Practice. BMC Fam. Pract. 2019;20:62. doi: 10.1186/s12875-019-0954-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-019-0954-3</ArticleId><ArticleId IdType="pmc">PMC6518816</ArticleId><ArticleId IdType="pubmed">31088382</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokop J.W., Hartog N.L., Chesla D., Faber W., Love C.P., Karam R., Abualkheir N., Feldmann B., Teng L., McBride T., et al. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals. Front. Immunol. 2021;12:694243. doi: 10.3389/fimmu.2021.694243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.694243</ArticleId><ArticleId IdType="pmc">PMC8322982</ArticleId><ArticleId IdType="pubmed">34335605</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>